In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Axcan licenses Abbott's gastrointestinal drug Itax

Executive Summary

Gastroenterology specialist Axcan Pharma has received exclusive rights to develop, manufacture, and market Abbott Laboratories' patented Itax (itopride hydrochloride) in North America, Latin America, and EU countries including the UK, France, Germany, Italy, and Spain.
Deal Industry
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • R&D and Marketing (Licensing)
    • Reverse Licensing

Related Companies